Search research articles
Contact Us
Filters
Showing results (121-130 of 223) with videos related to
Page
of 23
Sort By:
International Journal of Cancer
|
November 28, 2002
Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo
Stephan R Scheffer, Heike Nave, Firouzeh Korangy, et al.
Nature Communications
|
July 6, 2018
miR-130a and miR-145 reprogram Gr-1<sup>+</sup>CD11b<sup>+</sup> myeloid cells and inhibit tumor metastasis through improved host immunity
Hiroki Ishii, Suman K Vodnala, Bhagelu R Achyut, et al.
Anticancer Research
|
July 26, 2007
Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer
Veit Zieglschmid, Christiane Hollmann, Jenny Mannel, et al.
Hepatology (Baltimore, Md.)
|
June 25, 2009
Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
Bastian Hoechst, Torsten Voigtlaender, Lars Ormandy, et al.
The American Journal of Gastroenterology
|
January 8, 2010
Mycosis fungoides with involvement of the larynx after liver transplantation in an adult
Oktay Tutarel, Hannelore Barg-Hock, Sven Pischke, et al.
Iscience
|
January 25, 2021
Hydroxychloroquine can impair tumor response to anti-PD1 in subcutaneous mouse models
Simon Wabitsch, John C McVey, Chi Ma, et al.
Molecular Carcinogenesis
|
January 9, 2020
Loss of myeloid-specific lamin A/C drives lung metastasis through Gfi-1 and C/EBPε-mediated granulocytic differentiation
Hiroki Ishii, Woo-Yong Park, Jaeyoung So, et al.
Cell
|
August 6, 2004
IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer
Florian R Greten, Lars Eckmann, Tim F Greten, et al.
Cancer Immunology, Immunotherapy : CII
|
September 27, 2012
Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies
Austin Duffy, Fei Zhao, Lydia Haile, et al.
BMC Cancer
|
May 19, 2010
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
Tim F Greten, Alejandro Forner, Firouzeh Korangy, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 223) with videos related to
Sort By:
Page
of 23
International Journal of Cancer
|
November 28, 2002
Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo
Stephan R Scheffer, Heike Nave, Firouzeh Korangy, et al.
Nature Communications
|
July 6, 2018
miR-130a and miR-145 reprogram Gr-1<sup>+</sup>CD11b<sup>+</sup> myeloid cells and inhibit tumor metastasis through improved host immunity
Hiroki Ishii, Suman K Vodnala, Bhagelu R Achyut, et al.
Anticancer Research
|
July 26, 2007
Tumor-associated gene expression in disseminated tumor cells correlates with disease progression and tumor stage in colorectal cancer
Veit Zieglschmid, Christiane Hollmann, Jenny Mannel, et al.
Hepatology (Baltimore, Md.)
|
June 25, 2009
Myeloid derived suppressor cells inhibit natural killer cells in patients with hepatocellular carcinoma via the NKp30 receptor
Bastian Hoechst, Torsten Voigtlaender, Lars Ormandy, et al.
The American Journal of Gastroenterology
|
January 8, 2010
Mycosis fungoides with involvement of the larynx after liver transplantation in an adult
Oktay Tutarel, Hannelore Barg-Hock, Sven Pischke, et al.
Iscience
|
January 25, 2021
Hydroxychloroquine can impair tumor response to anti-PD1 in subcutaneous mouse models
Simon Wabitsch, John C McVey, Chi Ma, et al.
Molecular Carcinogenesis
|
January 9, 2020
Loss of myeloid-specific lamin A/C drives lung metastasis through Gfi-1 and C/EBPε-mediated granulocytic differentiation
Hiroki Ishii, Woo-Yong Park, Jaeyoung So, et al.
Cell
|
August 6, 2004
IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer
Florian R Greten, Lars Eckmann, Tim F Greten, et al.
Cancer Immunology, Immunotherapy : CII
|
September 27, 2012
Comparative analysis of monocytic and granulocytic myeloid-derived suppressor cell subsets in patients with gastrointestinal malignancies
Austin Duffy, Fei Zhao, Lydia Haile, et al.
BMC Cancer
|
May 19, 2010
A phase II open label trial evaluating safety and efficacy of a telomerase peptide vaccination in patients with advanced hepatocellular carcinoma
Tim F Greten, Alejandro Forner, Firouzeh Korangy, et al.
Page
of 23